The hypothesis to be tested is that the effects of interleukin-3 (IL-3) on proliferation of murine IL-3-dependent myeloid cell lines (and, by inference, normal murine myeloid stem cells) may be explained in terms of signal transduction mediated by guanine nucleotide binding regulatory proteins (G proteins). G proteins mediate the transduction of a remarkably diverse group of extracellular signals, to a relatively limited number of intracellular effector enzymes. The signal of interest in the proposed study is the growth factor peptide, IL-3, that exerts its action via binding to specific plasma membrane receptors on murine myeloid stem cells. As a result of our preliminary studies of IL-3 signal transduction at the cellular level, phosphatidylinositol 4,5, bisphosphate-specific phospholipase C will be a major focus of the proposed studies, in addition to the G proteins themselves. Using IL-3 dependent murine myeloid cell lines as the principal cellular system, we propose to: 1) characterize the early metabolic and late cellular responses to IL- 3 recetpor-ligand interaction, 2) purify and characterize the major G proteins from these cells, 3) purify and characterize the (IL-3)-stimulated phosphatidylinositol 4,5, bisphosphate-specific phsopholipase C from these cells. The early metabolic responses to IL-3 to be studied are those resulting from changes in phosphatidylinositol 4,5, bisphosphate-specific phospholipase C activity (as reflected by phosphoinositide 4,5, bisphosphate hyrolysis, sn 1, 2, discylglycerol generation, and inositol 1, 4, 5 trisphosphate generation). The molecular basis for IL-3 induced PIP2 hydroylsis will be studied by development of a reconstitution assay for G protein-coupled PIP2-specific phospholipase C enzymatic activity. This assay will be used in the subsequent purification of reconstitutively active G protein-coupled PIP2- specific phospholipase C from the plasma membranes of IL-3 dependent cell lines.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Rizzo, M T; Boswell, H S; English, D et al. (1991) Expression of val-12 mutant ras p21 in an IL-3-dependent murine myeloid cell line is associated with loss of serum-dependence and increases in membrane PIP2-specific phospholipase C activity. Cell Signal 3:311-9
Munshi, N C; Gabig, T G (1990) Growth factor-dependent initiation of DNA replication in nuclei isolated from an interleukin 3-dependent murine myeloid cell line. J Clin Invest 85:300-4
Boswell, H S; Nahreini, T S; Burgess, G S et al. (1990) A RAS oncogene imparts growth factor independence to myeloid cells that abnormally regulate protein kinase C: a nonautocrine transformation pathway. Exp Hematol 18:452-60
Boswell, H S; Harrington, M A; Burgess, G S et al. (1989) A mutant RAS gene acts through protein kinase C to augment interleukin-3 dependent proliferation in a fastidious immortal myeloid cell line. Leukemia 3:662-8
English, D; Broxmeyer, H E; Gabig, T G et al. (1988) Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor. J Immunol 141:2400-6
Akard, L P; English, D; Gabig, T G (1988) Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement by newly activated enzyme sustains the respiratory burst. Blood 72:322-7
Inhorn, L; Fleming, J W; Klingberg, D et al. (1988) Restoration of adenylate cyclase responsiveness in murine myeloid leukemia permits inhibition of proliferation by hormone. Butyrate augments catalytic activity of adenylate cyclase. Blood 71:1003-11